Home/Peptides/GLP-1 / GIP Receptor Agonists
GLP-1 / GIP Receptor Agonists
Peptides

GLP-1 / GIP Receptor Agonists

Tirzepatide (Mounjaro®) is a long-acting GIP and GLP-1 receptor agonist peptide designed for once-weekly administration. It is a synthetic peptide with a molecular weight of 4813.45 g/mol and a half-life of approximately 5 days.

$137.64USD
Purity=>99.4%
AvailabilityIn Stock
For research use onlyThis material is intended exclusively for laboratory research and analytical use. Not for human consumption.
Dosage / Format2.5 mg/0.5 mL
CAS Number2023788-19-2
Molecular FormulaC₂₂₅H₃₄₈N₄₈O₆₈
Storage36°F to 46°F (2°C to 8°C)
Product Overview

About GLP-1 / GIP Receptor Agonists

Mounjaro® (Tirzepatide) Product Name: Tirzepatide (Mounjaro®) Category: GLP-1 / GIP Receptor Agonist Peptide Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈ Molecular Weight: 4813.45 g/mol Half-Life: Approximately 5 days Storage Condition: Store refrigerated at 2°C–8°C. Protect from light. Do not freeze. Overview: Tirzepatide is a synthetic peptide compound that functions as a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It is designed to activate two incretin pathways that play important roles in metabolic regulation and scientific research. Product Features: - Dual-action GIP and GLP-1 receptor activity - Long-acting peptide structure suitable for once-weekly administration research models - High-quality peptide compound with identity and purity verification available through analytical testing - Suitable for laboratory and scientific research applications Technical Information: - CAS Number: 2023788-19-2 - Appearance: White to off-white lyophilized powder (when supplied as a research compound) - Formulation: Lyophilized peptide format - Testing: Identity and analytical testing available according to batch documentation Applications & Research Areas: - Peptide science research - Metabolic pathway studies - GLP-1 and GIP receptor research - Pharmaceutical research and development - Biological activity studies SEO Keywords: Tirzepatide peptide, Mounjaro peptide, GLP-1 receptor agonist, GIP receptor agonist, dual incretin peptide, metabolic research peptide, pharmaceutical peptide, peptide laboratory research, tirzepatide compound, advanced peptide research. Disclaimer: For research and laboratory use only where applicable. Not intended for human consumption or medical use unless approved and prescribed by a licensed healthcare professional.


Tirzepatide (Mounjaro®) is a long-acting GIP and GLP-1 receptor agonist peptide designed for once-weekly administration. It is a synthetic peptide with a molecular weight of 4813.45 g/mol and a half-life of approximately 5 days.


Store in a cool, dry environment: 36°F to 46°F (2°C to 8°C).

Researchers should follow appropriate laboratory handling, storage, and safety protocols. Review the batch documentation before beginning any analytical procedure.

Batch Documentation

Certificate of Analysis

Review available independent analytical documentation, including identity, purity, and batch-specific test results.

View Certificates
IdentityLC-MS Verified
Purity=>99.4%
TraceabilityBatch Specific
DocumentationDownloadable